We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
Cost-efficient R&D chemicals for drug discovery with a 70% gross margin.
days to go: Expired investment: £595,492
Farillio is a legal tech company who provide legal solutions and answers for SME’s in an online platform. The platform will provide knowledge jargon free, using how-to video sound bites, checklists, infographics and short easy to read guides.
days to go: Expired investment: £162,528
Driftrock are a digitasl media media marketing company who specialise in creating simple easy to use advertising tools.
days to go: Expired investment: £800,278
Please watch the video for more information
days to go: Expired investment: £311,669
 The Idle Man is a fast growing internet retailer with experienced founders. Within the third month of trading The Idle Man was already seeing £100,000 in monthly revenue. This funding round they are aiming to use the money gained from investments to continue their aggressive expansion. 
days to go: Expired investment: £1,283,974
Naked Energy has developed Virtu which is an evolution of standard solar technology.  Traditionally there are two types of technology; one takes the suns energy and converts it to electricity and the other to heat water.  Virtu takes both methods and fuses them together to create an efficient heat exchanger with vacuum tube technology.  They are now looking to grow internationally.
days to go: Expired investment: £1,200,858
Cardiovascular Disease is the leading cause of death in the UK, PlaqueTec have developed a Liquid Biopsy System, which allows cardiologists to gain further information from a patient's coronary artery and provide more effective treatment to those affected by the disease.
days to go: Expired investment: £1,493,593
Please watch the video for more information
days to go: Expired investment: £260,150
MGB Biopharma is tackling the worldwide threat of antimicrobial resistance.   The company is in the process of clinical study and designing a new class of antibiotic.  They are looking for investment to start phase 2 of the study with 70% being supported by a grant.
days to go: Expired investment: £1,309,621
Please watch the video for more information
days to go: Expired investment: £697,266
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph